Melvin Sharoky - May 11, 2022 Form 4 Insider Report for INSMED Inc (INSM)

Role
Director
Signature
/s/ Melvin Sharoky, M.D, by Michael Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
May 11, 2022
Transactions value $
$344,000
Form type
4
Date filed
5/13/2022, 06:15 PM
Previous filing
Mar 4, 2022
Next filing
Nov 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Award +14.6K +6.42% 243K May 11, 2022 Direct F1, F2
transaction INSM Common Stock Purchase $344K +20K +8.24% $17.20 263K May 11, 2022 Direct F3
holding INSM Common Stock 1.85K May 11, 2022 By spouse
holding INSM Common Stock 1.18K May 11, 2022 By Melvin Sharoky C/F Sophie C. Wink UTMA/FL F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.
F2 Each Restricted Stock Unit was granted on May 11, 2022, for no consideration.
F3 This is the weighted average sales price representing the shares purchased at prices ranging from $17.14 to $17.25 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.
F4 The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.